Uncategorized
CoreWeave Stock Is Moving Lower Wednesday: What’s Going On?
CoreWeave, Inc. (NASDAQ:CRWV) shares are trading lower on Wednesday. HC Wainwright & Co. initiated coverage on the stock with a Neutral rating. read more
Could Personalized Medicine Be Your Portfolio’s Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences. Latest Ratings for EXAS Date Firm Action From To Feb 2022 Wells Fargo Maintains Equal-Weight Feb 2022 Citigroup Maintains Neutral Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for EXAS View the…
What’s Going On With Robinhood Stock Today?
Robinhood Markets Inc (NASDAQ:HOOD) stock is trending on Wednesday after hitting all-time highs this week. Here’s a look at what you need to know. read more
Calamos Unveils Callable-Note ETF For Predictable Payouts
Calamos Investments launches CAIE, an ETF investing in autocallable notes for high, predictable monthly income. Backed by J.P. Morgan and MerQube. read more
15 Analysts Assess Honeywell Intl: What You Need To Know
Latest Ratings for HON Date Firm Action From To Mar 2022 Deutsche Bank Maintains Buy Feb 2022 UBS Maintains Buy Feb 2022 Wells Fargo Maintains Equal-Weight View More Analyst Ratings for HON View the Latest Analyst Ratings read more
A Glimpse Into The Expert Outlook On Shake Shack Through 17 Analysts
Latest Ratings for SHAK Date Firm Action From To Feb 2022 JP Morgan Maintains Underweight Feb 2022 Credit Suisse Maintains Neutral Feb 2022 Deutsche Bank Maintains Hold View More Analyst Ratings for SHAK View the Latest Analyst Ratings read more
What’g Going On With POET Technologies Stock Today?
Shares of POET Technologies Inc. (NASDAQ: POET) are trading higher Wednesday. The company received the 2025 AI Hardware Innovation Award and recently announced a new manufacturing partnership aimed at scaling production. read more
Did The FDA Make A Mistake? Sarepta’s Elevidys Approval Under Scrutiny
FDA is investigating Sarepta’s Elevidys after two deaths from liver failure in non-ambulatory DMD patients, raising safety and regulatory concerns. Latest Ratings for SRPT Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 RBC Capital Maintains Outperform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for SRPT View the…
What Analysts Are Saying About Waste Management Stock
Latest Ratings for WM Date Firm Action From To Mar 2022 JP Morgan Reinstates Neutral Oct 2021 Raymond James Maintains Outperform Jul 2021 Raymond James Maintains Outperform View More Analyst Ratings for WM View the Latest Analyst Ratings read more
